Sangamo Biosciences reported $14.91M in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Amgen AMGN:US $ 1.23B 197M
Avrobio Inc AVRO:US 10.16M 1.2M
Bayer BAYN:GR 3.94B 346M
Biocryst Pharmaceuticals BCRX:US $ 34.28M 1.1M
Biogen BIIB:US $ 634.9M 153M
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Gilead Sciences GILD:US $ 1.08B 567M
GlaxoSmithKline GSK:LN 2.68B 227M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
IONIS PHARMACEUT IONS:US $ 34.13M 3.47M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Karyopharm Therapeutics KPTI:US $ 38.77M 4.21M
Merk MRK:US $ 2.3B 518M
Novartis NOVN:VX 3.5B 486M
Regulus Therapeutics RGLS:US $ 2.89M 339K
Sangamo Biosciences SGMO:US $ 14.91M 1.18M
Sarepta Therapeutics SRPT:US $ 71.84M 6.22M
Ultragenyx Pharmaceutical RARE:US $ 67.31M 7.88M
Vertex Pharmaceuticals VRTX:US $ 215.2M 39.96M
Ziopharm Oncology ZIOP:US $ 3.5M 1.41M